News Column

Findings from University of Brasilia Broadens Understanding of Nanoparticles [trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] incorporated in PLGA...

July 11, 2014



Findings from University of Brasilia Broadens Understanding of Nanoparticles [trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] incorporated in PLGA nanoparticles for the delivery of nitric oxide to B16-F10 cells: cytotoxicity and phototoxicity]

By a News Reporter-Staff News Editor at Health & Medicine Week -- Investigators discuss new findings in Nanoparticles. According to news reporting originating from Brasilia, Brazil, by NewsRx correspondents, research stated, "The immobilization and characterization of trans-[Ru(NO)Cl(cyclam)](PF6)2 (cyclam=1,4,8,11-tetraazacyclotetradecane), and [Ru(NO)(Hedta)] (Hedta=ethylenediaminetetraacetic acid) entrapped in poly(d,l-lactic-co-glycolic) acid (PLGA) nanoparticles (NP) using the double emulsification process is described. Scanning electron microscopy and dynamic light scattering revealed that the particles are spherical in shape, have a size distribution between 220 and 840 nm of diameter, and have a tendency to aggregate confirmed by a zeta potential between -3.2 and +3.5 mV."

Our news editors obtained a quote from the research from the University of Brasilia, "Using this method the loading efficiency was 26% for trans-[Ru(NO)Cl(cyclam)](PF6)2 and 32% for [Ru(NO)(Hedta)]. The release of the complexes from the NPs shows that cyclam-NP and Hedta-NP exhibited a two-phase exponential association release pattern, which was characterized by an initial complex burst during the first 24 h, followed by a slower release phase complex profile, due to a few pores observed in surface of nanoparticles using atomic force microscopy. The in vitro cytotoxic activity of the nitrosyl complexes in solution and incorporated in PLGA nanoparticles on melanoma cancer cells (cell line B16-F10) was investigated. The lower cytotoxicity of trans-[RuCl(cyclam)(NO)]2+ (12.42.6%) and [Ru(NO)(Hedta)] (4.02.7%) in solution compared to that of trans-[Ru(NO)(NH3)4py]3+ (46.16.4%) is consistent with the rate constant release of NO of these complexes (k-NO=6.2 x 10(-4) s(-1), 2.0 x 10(-3) s(-1), and 6.0 x 10(-2) s(-1), respectively); the cytotoxicities are also inhibited in the presence of the NO scavenger carboxy-PTIO. The phototoxicity of these complexes is due to NO release, which lead to 53.86.2% of cell death in the presence of trans-[Ru(NO)Cl(cyclam)](PF6)2 and 22.35.1% in the presence of [Ru(NO)(Hedta)]. The PLGA nanoparticles loaded with trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] exerted in vitro a reduced activity against melanoma cells when compared to the activity of complex in solution (nonentrapped in nanoparticles). Blank PLGA nanoparticles did not exhibit cytotoxicity. In the presence of light and of ruthenium nitrosyl complexes or cyclam-NP and Hedta-NP, B16-F10 cells displayed a considerable damage of the surface with rupture of the plasma membrane."

According to the news editors, the research concluded: "This behavior is an indicative of the efficiency of the DDS to deliver the NO from the entrapped complex when photoinduced."

For more information on this research see: trans-[Ru(NO)Cl(cyclam)](PF6)2 and [Ru(NO)(Hedta)] incorporated in PLGA nanoparticles for the delivery of nitric oxide to B16-F10 cells: cytotoxicity and phototoxicity. Molecular Pharmaceutics, 2013;10(10):3544-54. (American Chemical Society - www.acs.org; Molecular Pharmaceutics - www.pubs.acs.org/journal/mpohbp)

The news editors report that additional information may be obtained by contacting A.J. Gomes, Faculdade de Ceilandia, Universidade de Brasilia , Brasilia, DF, Brazil. Additional authors for this research include E.M. Espreafico and E. Tfouni (see also Nanoparticles).

Keywords for this news article include: Brazil, Brasilia, Chemicals, Chemistry, Nitric Oxide, South America, Nanotechnology, Emerging Technologies.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC


For more stories covering the world of technology, please see HispanicBusiness' Tech Channel



Source: Health & Medicine Week


Story Tools






HispanicBusiness.com Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters